Hyunjong Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Prognostic value of [18F]fluorodeoxyglucose PET/CT in esophageal cancer patients treated with anti-PD-1 inhibitors.

Prognostic value of [18F]fluorodeoxyglucose PET/CT in esophageal cancer patients treated with anti-PD-1 inhibitors.

Journal: BMC medical imaging

Published: April 03, 2026

Enhanced Efficacy and Safety of 177Lu-Anti-CD25 Radioimmunotherapy by Combination with Targeted Anticancer Agents.

Enhanced Efficacy and Safety of 177Lu-Anti-CD25 Radioimmunotherapy by Combination with Targeted Anticancer Agents.

Journal: Molecular pharmaceutics

Published: March 03, 2026

Tracking MAPK-Dependent CD38 Upregulation by All-Trans Retinoic Acid in Human Leukemia Using 89Zr Immuno-PET.

Tracking MAPK-Dependent CD38 Upregulation by All-Trans Retinoic Acid in Human Leukemia Using 89Zr Immuno-PET.

Journal: Molecular pharmaceutics

Published: February 07, 2026

Minimal Additional Effect of Heparin Bolus Beyond Prolonged Fasting on Cardiac 18F-FDG Suppression in Infectious Disease PET/CT Evaluation: Inverse Association Between Myocardial 18F-FDG Uptake and CRP.

Minimal Additional Effect of Heparin Bolus Beyond Prolonged Fasting on Cardiac 18F-FDG Suppression in Infectious Disease PET/CT Evaluation: Inverse Association Between Myocardial 18F-FDG Uptake and CRP.

Journal: Nuclear medicine and molecular imaging

Published: November 25, 2025

Integrating TERT promoter mutations into risk stratification of papillary thyroid cancer.

Integrating TERT promoter mutations into risk stratification of papillary thyroid cancer.

Journal: Endocrine connections

Published: November 06, 2025

Identification and Validation of a Novel Theranostic Target in Triple Negative Breast Cancer with Transcriptomics and Protein Analyses.

Identification and Validation of a Novel Theranostic Target in Triple Negative Breast Cancer with Transcriptomics and Protein Analyses.

Journal: Breast cancer (Dove Medical Press)

Published: September 24, 2025

Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ductal Adenocarcinoma.

Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Academic radiology

Published: August 21, 2025

Correlation Between Clinical Characteristics and Image Parameters of Preoperative 18F-fluorocholine PET/CT in Hyperparathyroidism Patients.

Correlation Between Clinical Characteristics and Image Parameters of Preoperative 18F-fluorocholine PET/CT in Hyperparathyroidism Patients.

Journal: Nuclear medicine and molecular imaging

Published: June 09, 2025

177Lu-Anti-CD25 Antibody for Interleukin-2 Receptor-α-Targeted Radioimmunotherapy of SUDHL1 Lymphomas in Mice.

177Lu-Anti-CD25 Antibody for Interleukin-2 Receptor-α-Targeted Radioimmunotherapy of SUDHL1 Lymphomas in Mice.

Journal: Molecular pharmaceutics

Published: May 23, 2025

Prognostic value of [18F]fluorodeoxyglucose PET/CT in the new staging system for non-small cell lung cancer.

Prognostic value of [18F]fluorodeoxyglucose PET/CT in the new staging system for non-small cell lung cancer.

Journal: European radiology

Published: February 18, 2025

18F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.

18F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.

Journal: Anticancer research

Published: January 27, 2025

Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors.

Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors.

Journal: Breast cancer research : BCR

Published: October 08, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026